Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine
Clinical trial NCT00550004 · TERMINATED
Trial details
- NCT number
- NCT00550004
- Sponsor
- SciClone Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2009-08-01
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.